InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
fat_tire Free
08/11/22 10:02 PM
profile icon
JMoneyHoops Free
08/10/22 11:17 AM
profile icon
cleanliving Free
08/09/22 1:49 AM
profile icon
De302 Free
08/04/22 10:49 AM
profile icon
Blue Skys PremiumMember
08/03/22 3:50 PM
profile icon
Yaafah Terminated
08/03/22 11:15 AM
profile icon
cleanliving Free
08/03/22 2:06 AM
profile icon
ChuckBits PremiumMember
08/02/22 10:59 PM
profile icon
Blue Skys PremiumMember
08/02/22 6:47 PM
profile icon
Blue Skys PremiumMember
08/02/22 3:50 PM
profile icon
Yaafah Terminated
08/02/22 3:37 PM
profile icon
Blue Skys PremiumMember
08/01/22 6:41 PM
profile icon
Joemarly Free
08/01/22 5:17 PM
profile icon
Yaafah Terminated
08/01/22 1:38 PM
profile icon
PhenixBleu Free
08/01/22 1:26 PM
profile icon
Blue Skys PremiumMember
07/28/22 1:41 PM
profile icon
Blue Skys PremiumMember
07/27/22 8:43 PM
profile icon
Joemarly Free
07/26/22 8:11 PM
profile icon
Blue Skys PremiumMember
07/26/22 6:20 PM
profile icon
De302 Free
07/26/22 1:31 PM
profile icon
De302 Free
07/26/22 10:59 AM
profile icon
Snizzle Free
07/24/22 8:01 AM
profile icon
ChuckBits PremiumMember
07/23/22 11:50 PM
profile icon
Yaafah Terminated
07/23/22 10:42 PM
profile icon
Yaafah Terminated
07/23/22 10:36 PM
profile icon
ChuckBits PremiumMember
07/23/22 10:22 PM
profile icon
Snizzle Free
07/23/22 8:35 PM
profile icon
Yaafah Terminated
07/23/22 5:36 PM
profile icon
Yaafah Terminated
07/23/22 5:36 PM
profile icon
ChuckBits PremiumMember
07/23/22 12:10 AM
profile icon
gypsy11 Free
07/22/22 4:58 PM
profile icon
Joemarly Free
07/22/22 4:30 PM
profile icon
Yaafah Terminated
07/21/22 3:27 PM
profile icon
swamp boy Free
07/21/22 3:11 PM
profile icon
JMoneyHoops Free
07/21/22 2:54 PM
profile icon
Blue Skys PremiumMember
07/21/22 12:45 PM
profile icon
JMoneyHoops Free
07/19/22 9:00 PM
profile icon
JMoneyHoops Free
07/15/22 6:53 PM

OWC Pharmaceutical Research Corp (OWCP) RSS Feed

Followers
1038
Posters
Posts (Today)
0
Posts (Total)
203907
Created
01/12/10
Type
Free
Moderators Blue Skys
 

SHAREHOLDER ALERT!  

If you lost money during the Friedland fraud timeline
of 11/18/2016-09/22/2017, you may be eligible for compensation!


jeffreyfriedlandfairfund.com

 



"Transforming cannabis into scientifically proven and clinically approved medical solutions"

U.S. Patent 10,603,301 Issued March 31, 2020 - Cannabis-Based Extracts and Topical Formulations for Use in Skin Disorders



-- NATIONAL INSTITUTE OF HEALTH CLINICAL TRIALS --



OWC Pharmaceutical Research Corp. (OWCP)
A Delaware Corporation since March 6, 2008

11 Anne Frank Street
Petah Tikva, Israel 4931113



Expert Market Icon
EXPERT MARKET


         
EDGAR FACEBOOK OTC PROFILE TWITTER WEBSITE
 


OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd. ("OWC"), of conducting
medical research and clinical trials, in full compliance with all international regulatory protocols, for the development and improvement of strains of medical cannabis
specifically designed for the treatment of several illnesses/medical conditions including Multiple Myeloma, Psoriasis, Fibromyalgia, Migraine, and PTSD.

 Our business plan includes entering into collaborative ventures with major medical centers and highly regarded researchers in Israel and potentially
other countries with the goal of developing novel therapeutic methods for the treatment of serious medical conditions with cannabis-based therapies and are
conducting pre-clinical investigations and randomized, placebo-controlled trials of cannabis-based compounds and develop unique, condition-specific products.

 

AUTHORIZED  500,000,000 OUTSTANDING  497,498,338 FLOAT  206,509,849
TA Verified 07/01/20 TA Verified 07/01/20 02/09/20


-- Research --
 


Therapies for Skin Diseases
 
Delivery System for Pain Management Multiple Myeloma



--Intellectual Property--

ALL PUBLISHED PATENT APPLICATIONS NAME ONE WORLD CANNABIS AS THE ASSIGNEE (OWNER)

OWCP's Intellectual Property Portfolio comprises 9 patent families and includes 31 filings in selected domains at various stages from PCT filings, National Phase filings
and Continuations in Part (CIP).  The National Phase is the second of the two main phases of the Patent Cooperation Treaty (PCT) procedure. It follows the international phase and consists
of the processing of the international application before each office of or acting for a contracting state of the PCT that has been designated in the international application.

The table below will be updated when the  unknown patent families and additional patent applications are identified.

RICHTER & SHIMONI
OWC's main Patent Agency located in Israel, Germany and Switzerland
Richter engages patent lawyers in other domains for filing purposes
Dr. Gila Shimoni is primary author/editor of patent application content


BROWDY & NEIMARK'S WEBSITE (USPTO)
Browdy is OWC's U.S. Intellectual Property Law Firm

DENNEMEYER & CO. WEBSITE (AUSPAT)

Chronic Pain - Emulsions
ACTIONS TAKEN WITHIN PAST 30 DAYS

PATENT GRANTS
     AUSPAT (Australia) (AU)     Canadian Intellectual Property Office (CA)    Czech IPO (CZ)    European Patent Register (EPR)    Israel Patent Office (IL)     US Patent & Trademark Office (USPTO)       WIPO Patentscope (WIPO)
To search for USPTO Patent records, enter the Application Number in the search field.  View documents under Image File Wrapper tab.  To download, check the box in far right column, then click on PDF button above it.

Count Patent Family Invention Name Application No. Filing
Date
Filing
Domain
Application
Published
Last Action Last Action Date Patent No. Patent Granted
1   Multiple Myeloma 1 Novel Cannabinoid Combination Therapies for Multiple Myeloma (MM) PCT/IL2016/050608 06.09.2016 WIPO 12.15.2016        
2   " 2016276563 06.09.2016 AU 12.15.2016 Exam Report #1 10.01.2020    
3   " 2988869 06.09.2016 CA 12.15.2016 Renewal
Fee Paid
06.09.2020    
4   " 15580718 06.09.2016 USPTO 05.07.2018 Non-Final
Rejection
05.12.2020    
5   " 16807035 06.09.2016 EPR 04.18.2018 Examination Report Received 05.07.2021    
6   " 256209 06.11.2015 IS 02.28.2018 Incoming Correspondence 04.28.2020    
7   Multiple Myeloma 2 Synergistic Use of Cannabis for Treating Multiple Myeloma (MM) PCT/IL2015/051138 11.24.2015 WIPO 02.06.2016        
8   " 15/863,361 11.24.2015 EPR 04.10.2017 Notice drawing attention to fee 01.13.2021 Intent to Grant Intent to Grant
9   " 2015351937 11.24.2015 AU 02.06.2016 Lapsed - Continuation Fee Not Paid 06.08.2021    
10   " 2968929 11.24.2015 CA 02.06.2016 Abandoned
Failure to Request Examination
02.15.2021    
11   " 252504 11.26.2014 IS 07.31.2017 Abandoned 01.20.2021    
12   " 15531047 11.24.2015 USPTO 10.25.2018 Abandonment 10.10.2019    
13   Fibromyalgia Use of Cannabis to Treat Fibromyalgia, Methods and Compositions Thereof PCT/IL2016/050498 05.11.2016 WIPO 11.17.2016        
14   " 2016261707 05.11.2016 AU 11.17.2016 Exam Response Reminder #2 (Exam report #1 was 06/30/2020) 05.06.2021    
15   " 2985969 05.11.2016 CA 11.17.2016 Renewal
Fee Paid
05.07.2020    
16   " 16792308.5 05.11.2016 EPR 03.21.2018 Despatch of Exam Report + Time Limit 02.10.2021    
17   " 15573687 05.11.2016 USPTO 05.03.2018 Abandonment 02.20.2020    
18   " 255615 05.13.2015 IS 01.31.2018 Claims w/marked changes 10.18.2020    
19   Pharmaceutical Emulsions Preparations of Cannabis Emulsions and Methods Thereof   PCT/IL2016/050289 03.17.2016 WIPO 09.22.2016        
20   " 16764344 03.17.2016 EPR 01.24.2018 Renewal
Fee Reminder
05.07.21    
21   " 2982250 03.17.2016 CA 09.22.2016 Renewal
Fee Paid
03.09.2020    
22   " 2016231788 03.17.2016 AU 09.22.2016 Lapsing for non-payment of fees 02.10.2021    
23   " 15708187 09.19.2017 USPTO 02.15.2018 Amendments/RFR Forwarded to Examiner 07.10.2020    
24   " 254598 03.19.2015 IS 11.20.2017 Claims w/Marked Changes 09.21.2020    
25   Migraine Use of Cannabis to Treat Migraine   PCT/IL2015/051184 07.12.2015 WIPO 06.16.2016        
26   " 15533684 06.07.2017 USPTO 10.11.2018 Abandonment 07.11.2019    
27   " EP15863361 11.24.2015 EPR 04.10.2017 Deemed Withdrawn 10.26.2018    
28   Sexual Function Novel Condom Comprising Cannabis Derived Compositions for Enhancement of Sexual Pleasure and Decrease of Erectile Dysfunction Symptoms PCT/IL2015/051220 16.12.2015 WIPO 06.23.2016        
29   " 15536738 16.12.2015 USPTO 12.28.2017 Final Rejection 07.22.2020    
30   " EP15869472 16.12.2015 EPR 06.23.2016 Deemed
Withdrawn
07.27.2018    
31   " 2971144 12.17.2014 CA 06.23.2016 Renewal
Fee Paid
12.02.2019    
32 Skin Disorders Use of Cannabis to Treat Psoriasis* PCT/IL2015/051234 12.21.2015 WIPO 06.30.2016 Deemed
Withdrawn
06.22.2018    
33 Skin Disorders Cannabis-Based Extracts and Topical Formulations for Use in Skin Disorders 2015101908 12.21.2015 AU 06.30.2016 GRANTED   2015101908 11.08.2017
34   " 253066 12.21.2014 IS 08.31.2017 Application w/marked changes 09.03.2020    
35   " 15629230 06.21.2017 USPTO 02.15.2018 GRANTED   10,603,301 03.31.2020
36   " 2971197 06.20.2017 CA 12.20.2018 Renewal
Fee Paid
06.19.2020    
37   " 17178303 06.28.2017 EPR 12.26.2018 Reply to Examination Report 12.24.2020    
38 Skin Disorders Hemp extracts and topical preparations for use in skin disorders 2017-33913 7.14.2017 CZ 10.31.2018 GRANTED     01.01.2019

*The Psoriasis agreement with Sheba Academic Medical Center provides that all intellectual property that is conceived during the course of the research is to be jointly owned by Sheba and One World Cannabis.

 

 
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
OWCP Latest News
  • No Recent News Available for this company!
New Post